ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes

NCT02840617 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Indocyanine Green (ICG)

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University